Can real-world evidence save pharma US$1 billion per year? A framework for an integrated evidence generation strategy. | J Comp Eff Res;9(2): 79-82, 2020 01. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

Virtual Health Library

United States - Mexico Border

Subject descriptor lookup Advanced Search

Can real-world evidence save pharma US$1 billion per year? A framework for an integrated evidence generation strategy.

Olson, Melvin Skip.

Affiliation

Olson MS; Real-World Data Strategy & Innovation, RWE & Digital, Novartis Pharma AG, Novartis Campus, Fabrikstr. 6, 4056 Basel, Switzerland.

J Comp Eff Res ; 9(2): 79-82, 2020 01.

Article in En | MEDLINE | ID: mdl-31774337

Key words

RWD; clinical trial efficiency; evidence planning; health technology assessment; market access; operating model; product life cycle; real-world data; real-world evidence; regulatory

Search on Google

Full text: 1 Database: MEDLINE Type of study: Health_technology_assessment Language: En Year: 2020 Type: Article

Search on Google

Full text: 1 Database: MEDLINE Type of study: Health_technology_assessment Language: En Year: 2020 Type: Article